Hasil Pencarian - Schuitemaker H

  • Menampilkan 1 - 10 hasil dari 10
Perbaiki Hasil
  1. 1
    P04-50 LB. Prevalence of cross-reactive HIV-1 neutralizing activity in HIV-1 infected patients with rapid or slow disease progression

    P04-50 LB. Prevalence of cross-reactive HIV-1 neutralizing activity in HIV-1 infected patients with rapid or slow disease progression oleh Schuitemaker H, Wrin T, Schweighardt B, Euler Z, van Gils MJ

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    P07-04. HIV-1 evolution in mother to child transmission and pediatric disease progression

    P07-04. HIV-1 evolution in mother to child transmission and pediatric disease progression oleh Scarlatti G, Schuitemaker H, van Nuenen A, Cavarelli M, Dispinseri S

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    P09-14. Emergence of b12 resistant rapidly replication HIV-1 variants during natural infection in the absence of humoral or cellular immune pressure

    P09-14. Emergence of b12 resistant rapidly replication HIV-1 variants during natural infection in the absence of humoral or cellular immune pressure oleh Schuitemaker H, van Nuenen A, Pisas L, Lobbrecht M, Bunnik E

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    P04-49 LB. Adaptation of HIV-1 envelope glycoprotein to humoral immunity at a population level

    P04-49 LB. Adaptation of HIV-1 envelope glycoprotein to humoral immunity at a population level oleh Schuitemaker H, Prins J, Grijsen M, Welkers M, Euler Z, Bunnik EM

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals

    HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals oleh van den Kerkhof TL, Euler Z, van Gils MJ, Boeser-Nunnink BD, Verwer NL, Schuitemaker H, Sanders RW

    Diterbitkan 2012-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    OA06-05. Adaptation of HIV-1 to the human immune system at the population level is driven by protective HLA-B alleles

    OA06-05. Adaptation of HIV-1 to the human immune system at the population level is driven by protective HLA-B alleles oleh Schuitemaker H, Kesmir C, Miedema F, Kootstra N, Berkhout B, Boeser-Nunnink B, van Deutekom HW, Navis M, Schellens IM, van Baarle D, Borghans JA

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization

    Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization oleh Heyndrickx L, Stewart-Jones G, Schuitemaker H, Bowles E, Buonaguro L, Jansson M, Grevstad B, Vinner L, Ramaswamy M, Biswas P, Scarlatti G, Vanham G, Fomsgaard A

    Diterbitkan 2012-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    P19-20. Allogeneic stimulation of the anti-viral APOBEC3G in human CD4+ T cells and prevention of SHIV infectivity in macaques immunized with HLA antigens

    P19-20. Allogeneic stimulation of the anti-viral APOBEC3G in human CD4+ T cells and prevention of SHIV infectivity in macaques immunized with HLA antigens oleh Yang G, Babaahmady K, Seidl T, Pido-Lopez J, Vaughan R, Shaw O, Schuitemaker H, Bunnik E, Bergmeier LA, Singh M, Wyatt R, Scholler J, Whittall T, Wang Y, Thorstensson R, Biberfeld G, Lehner T

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group

    P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group oleh Polonis V, Osmanov S, Morris L, Moog C, Montefiori D, Malnati M, Lopalco L, Jansson M, Holmes H, Heyndrickx L, Heath A, Fenyö E, Bongertz V, Alcami J, Scarlatti G, Ramaswamy M, Sattentau Q, Schuitemaker H, Wrin T

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    P19-08. Immunisation with recombinant HLA class I and II, HIV-1gp140 and SIVp27 antigens elicits protection against SHIV-SF162P4 infection in rhesus macaques

    P19-08. Immunisation with recombinant HLA class I and II, HIV-1gp140 and SIVp27 antigens elicits protection against SHIV-SF162P4 infection in rhesus macaques oleh Schuitemaker H, Wyatt RT, Shao Y, Yang G, Vaughan R, Singh M, Bergmeier LA, Wang Y, Seidl T, Shaw O, Pihlainen E, Bergqvist L, Wehlin L, Bunnik E, Jansson M, Schøller J, Mörner A, Biberfeld G, Thorstensson R, Lehner T

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: